Browsing Tag
Equillium
2 posts
Equillium secures financing to launch EQ504 Phase 1 trial in 2026
Equillium secures up to $50M to fund clinical entry of EQ504 mid-2026—discover how this financing shapes its immunology strategy.
Equillium acquires Bioniz Therapeutics to expand immunomodulatory drug pipeline
Equillium, a Nasdaq-listed biotech company, has acquired Bioniz Therapeutics in a deal worth up to around $329 million,…